Kshama Oza

Kshama Oza has a diverse work experience in the field of biomedical research and pharmaceuticals. Kshama is currently working at Sutro Biopharma, Inc. as a Sr. Scientist in Preclinical Pharmacology, a position they started in March 2022. Prior to that, they worked as a Scientist in Preclinical Pharmacology at the same company from May 2020 to February 2022.

Before joining Sutro Biopharma, Inc., Kshama worked at Surface Oncology Inc. as a Scientist from January 2019 to April 2020. Kshama also worked as a Postdoctoral Research Associate at Boston University School of Medicine from September 2017 to December 2018.

In addition to their research positions, Kshama also attended workshops and hackathons at Novartis and Novartis Institutes for BioMedical Research (NIBR) in 2018. Kshama participated in an Academia to Industry Hackathon and a D3 Project Simulation workshop. Kshama also worked as a Summer Worker in the Early Discovery Group at Takeda Oncology from June 2017 to September 2017.

Kshama's educational background includes a Molecular Toxicology PhD from the University of Maryland School of Medicine, which they pursued from August 2012 to May 2017. During their PhD, they conducted two research projects related to the sensitization of leukemia to chemotherapy drugs and the effect of Pim kinase antagonists on multi drug-resistance proteins. Prior to their PhD, Kshama earned a Masters of Science in Molecular Medicine from the University of Maryland School of Medicine from August 2010 to June 2012. Kshama also holds a Bachelor of Pharmaceutical Sciences degree from the Institute Of Chemical Technology, which they completed from August 2006 to May 2010.

Kshama Oza's education history begins in 2006 when they earned a Bachelor's degree in Pharmaceutical Sciences from the Institute Of Chemical Technology. From 2010 to 2012, Kshama Oza pursued a Masters degree in Molecular Medicine at the University of Maryland School of Medicine. They continued their education at the same institution from 2012 to 2017, obtaining a Doctor of Philosophy degree in Molecular Toxicology.